CO6700877A2 - Derivado de difenil sulfuro y producto farmacéutico que contiene el mismo como ingrediente activo - Google Patents
Derivado de difenil sulfuro y producto farmacéutico que contiene el mismo como ingrediente activoInfo
- Publication number
- CO6700877A2 CO6700877A2 CO13120944A CO13120944A CO6700877A2 CO 6700877 A2 CO6700877 A2 CO 6700877A2 CO 13120944 A CO13120944 A CO 13120944A CO 13120944 A CO13120944 A CO 13120944A CO 6700877 A2 CO6700877 A2 CO 6700877A2
- Authority
- CO
- Colombia
- Prior art keywords
- diphenyl sulfide
- sulfide derivative
- pharmaceutical product
- active ingredient
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/664—Amides of phosphorus acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4015—Esters of acyclic unsaturated acids
Abstract
(Problema] Para proporcionar un derivado de difenil sulfuro que es útil como un producto farmacéutico que tiene excelente antagonista S1P3.(Solución] Los inventores han descubierto que un derivado de difenil sulfuro representado por general fórmula (1) (en donde R1 representa un grupo alcoxi que tiene 1-6 átomos de carbono, R2 representa un grupo propilo o un grupo alilo, X representa metileno o un átomo de oxígeno, y Z representa un átomo de halógeno) tiene excelente actividad antagonista S1P3 como un resultado de investigaciones extensivas para la producción de un compuesto que tiene actividad antagonista S1P3.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010284150 | 2010-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6700877A2 true CO6700877A2 (es) | 2013-06-28 |
Family
ID=46313476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO13120944A CO6700877A2 (es) | 2010-12-21 | 2013-05-16 | Derivado de difenil sulfuro y producto farmacéutico que contiene el mismo como ingrediente activo |
Country Status (19)
Country | Link |
---|---|
US (1) | US8993543B2 (es) |
EP (1) | EP2657241B1 (es) |
JP (1) | JP5795333B2 (es) |
KR (1) | KR20140020240A (es) |
CN (1) | CN103261209B (es) |
AU (1) | AU2011346254B2 (es) |
BR (1) | BR112013015701A2 (es) |
CA (1) | CA2817688A1 (es) |
CL (1) | CL2013001329A1 (es) |
CO (1) | CO6700877A2 (es) |
IL (1) | IL226048A (es) |
MX (1) | MX2013005568A (es) |
MY (1) | MY161036A (es) |
NZ (1) | NZ610866A (es) |
RU (1) | RU2566296C2 (es) |
SA (1) | SA111330084B1 (es) |
SG (1) | SG190816A1 (es) |
TW (1) | TWI519539B (es) |
WO (1) | WO2012086184A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2015194157A1 (ja) * | 2014-06-16 | 2017-04-20 | 杏林製薬株式会社 | ジフェニルスルフィド誘導体の製造方法及び製造中間体 |
JPWO2016013225A1 (ja) * | 2014-07-24 | 2017-04-27 | 杏林製薬株式会社 | ジフェニルスルフィド誘導体の製造方法及び製造中間体 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1424078A4 (en) | 2001-09-04 | 2009-03-25 | Ono Pharmaceutical Co | RESPIRATORY DISEASE MEDICINES COMPRISING A SPHINGOSINE-1-PHOSPHATE RECEPTOR REGULATING AGENT |
JP4217620B2 (ja) | 2001-09-27 | 2009-02-04 | 杏林製薬株式会社 | ジアリールスルフィド誘導体とその付加塩及び免疫抑制剤 |
WO2003029184A1 (fr) | 2001-09-27 | 2003-04-10 | Kyorin Pharmaceutical Co., Ltd. | Derive d'ether de diaryle, son sel d'addition et son immunosuppresseur |
KR101003877B1 (ko) | 2002-09-19 | 2010-12-30 | 교린 세이야꾸 가부시키 가이샤 | 아미노알코올 유도체와 그 부가염 및 면역 억제제 |
CN100344638C (zh) | 2003-02-18 | 2007-10-24 | 杏林制药株式会社 | 氨基膦酸衍生物、其加成盐以及s1p受体调节剂 |
WO2005044478A2 (en) | 2003-10-20 | 2005-05-19 | International Resistive Company | Resistive film on aluminum tube |
JP2005247691A (ja) | 2004-03-01 | 2005-09-15 | Toa Eiyo Ltd | S1p3受容体拮抗薬 |
MX2007006706A (es) | 2004-12-06 | 2007-10-18 | Univ Virginia | Analogos de esfingosina 1-fosfato amida de arilo. |
WO2007043568A1 (ja) | 2005-10-12 | 2007-04-19 | Toa Eiyo Ltd. | S1p3受容体拮抗剤 |
WO2008019090A2 (en) | 2006-08-04 | 2008-02-14 | Praecis Pharmaceuticals Incorporated | Agonists of the sphingosine-1-phosphate receptor |
MY152176A (en) | 2006-08-08 | 2014-08-15 | Kyorin Seiyaku Kk | Amino phosphate derivative and s1p receptor modulator having same as an active ingredient |
JP2010013407A (ja) * | 2008-07-04 | 2010-01-21 | Kyorin Pharmaceut Co Ltd | アミノアルコール誘導体 |
JP2010077053A (ja) * | 2008-09-25 | 2010-04-08 | Kyorin Pharmaceut Co Ltd | フェノール誘導体及びそれらを有効成分とする医薬 |
JP5616342B2 (ja) * | 2009-07-09 | 2014-10-29 | 杏林製薬株式会社 | ジフェニルスルフィド誘導体及びそれらを有効成分とする医薬 |
JP2011032226A (ja) * | 2009-08-03 | 2011-02-17 | Kyorin Pharmaceutical Co Ltd | ジフェニルスルフィド誘導体及びそれらを有効成分とする医薬 |
SG185746A1 (en) * | 2010-05-06 | 2013-01-30 | Novartis Ag | Treatment of autoimmune diseases |
JP2013525469A (ja) * | 2010-05-06 | 2013-06-20 | ノバルティス アーゲー | ジアリールスルフィド誘導体の投与レジメン |
-
2011
- 2011-11-28 TW TW100143514A patent/TWI519539B/zh not_active IP Right Cessation
- 2011-12-19 SA SA111330084A patent/SA111330084B1/ar unknown
- 2011-12-20 WO PCT/JP2011/007111 patent/WO2012086184A1/ja active Application Filing
- 2011-12-20 MY MYPI2013001735A patent/MY161036A/en unknown
- 2011-12-20 KR KR1020137018833A patent/KR20140020240A/ko not_active Application Discontinuation
- 2011-12-20 AU AU2011346254A patent/AU2011346254B2/en not_active Ceased
- 2011-12-20 CN CN201180061536.9A patent/CN103261209B/zh not_active Expired - Fee Related
- 2011-12-20 MX MX2013005568A patent/MX2013005568A/es active IP Right Grant
- 2011-12-20 BR BR112013015701A patent/BR112013015701A2/pt not_active IP Right Cessation
- 2011-12-20 CA CA2817688A patent/CA2817688A1/en not_active Abandoned
- 2011-12-20 NZ NZ610866A patent/NZ610866A/en not_active IP Right Cessation
- 2011-12-20 SG SG2013037569A patent/SG190816A1/en unknown
- 2011-12-20 US US13/883,847 patent/US8993543B2/en not_active Expired - Fee Related
- 2011-12-20 EP EP11850843.1A patent/EP2657241B1/en active Active
- 2011-12-20 JP JP2012549635A patent/JP5795333B2/ja not_active Expired - Fee Related
- 2011-12-20 RU RU2013133810/04A patent/RU2566296C2/ru not_active IP Right Cessation
-
2013
- 2013-04-29 IL IL226048A patent/IL226048A/en not_active IP Right Cessation
- 2013-05-14 CL CL2013001329A patent/CL2013001329A1/es unknown
- 2013-05-16 CO CO13120944A patent/CO6700877A2/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CL2013001329A1 (es) | 2014-02-07 |
MX2013005568A (es) | 2013-08-26 |
RU2013133810A (ru) | 2015-01-27 |
AU2011346254B2 (en) | 2016-08-04 |
KR20140020240A (ko) | 2014-02-18 |
EP2657241A4 (en) | 2014-07-02 |
JP5795333B2 (ja) | 2015-10-14 |
RU2566296C2 (ru) | 2015-10-20 |
IL226048A (en) | 2016-04-21 |
CN103261209B (zh) | 2016-07-13 |
AU2011346254A1 (en) | 2013-06-06 |
JPWO2012086184A1 (ja) | 2014-05-22 |
US20130261089A1 (en) | 2013-10-03 |
WO2012086184A1 (ja) | 2012-06-28 |
NZ610866A (en) | 2015-01-30 |
EP2657241A1 (en) | 2013-10-30 |
SA111330084B1 (ar) | 2014-07-02 |
BR112013015701A2 (pt) | 2016-10-11 |
EP2657241B1 (en) | 2017-07-12 |
CN103261209A (zh) | 2013-08-21 |
CA2817688A1 (en) | 2012-06-28 |
MY161036A (en) | 2017-04-14 |
TW201307373A (zh) | 2013-02-16 |
SG190816A1 (en) | 2013-07-31 |
IL226048A0 (en) | 2013-06-27 |
US8993543B2 (en) | 2015-03-31 |
TWI519539B (zh) | 2016-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201690019A1 (ru) | Производное аминотриазина и содержащая его фармацевтическая композиция | |
CY1123670T1 (el) | Κρυσταλλικο παραγωγο 6,7-ακορεστης-7-καρβαμοϋλ μορφινανης, και μεθοδος για την παραγωγη αυτου | |
MA34006B1 (fr) | Derives de dihydrofurane utilises comme composes insecticides | |
PH12015502232A1 (en) | Naphthyridine derivatives useful as alpha-v-beta-6 integrin antagonists | |
RS53301B (en) | TIOACETATE COMPOUNDS, COMPOSITIONS AND USE PROCEDURES | |
EA201400247A1 (ru) | Сельскохозяйственная и садоводческая фунгицидная композиция | |
RS54730B1 (sr) | Inhibitori beta sekretaze | |
UA111626C2 (uk) | Похідні дигідрохінолін-2-ону | |
RS54526B1 (en) | USE OF PIRAZOLOSPIROKETONE DERIVATIVES AS ACETYL-COA CARBOXYLASE INHIBITORS | |
EA201270216A1 (ru) | Фармацевтический состав | |
CO6531496A2 (es) | Amidas sustituidas con halógenoalquilo como insecticidas y acaricidas | |
ECSP11011244A (es) | Nuevos herbicidas. | |
BR112013018732A2 (pt) | novos derivados de amida de aril-benzocicloalquila | |
EA201100612A1 (ru) | Новые производные 2-амидотиадиазола | |
EA201291376A1 (ru) | Новые кальциевые соли соединения в качестве противовоспалительных, иммуномодулирующих и антипролиферативных агентов | |
GT201400167A (es) | Nuevos derivados de bencil sulfonamida utiles como inhibidores de mogat-2 | |
EA201490754A1 (ru) | Производные карбамата/мочевины, содержащие пиперидиновые и пиперазиновые кольца, в качестве ингибиторов н3 рецептора | |
UA113086C2 (xx) | Піразольні сполуки як інгібітори sglt1 | |
EA201491288A1 (ru) | ФАРМАЦЕВТИЧЕСКИЙ ПРЕПАРАТ, СОДЕРЖАЩИЙ БРЕКСПИПРАЗОЛ И ЗАМЕЩЕННЫЙ β-ЦИКЛОДЕКСТРИН | |
EA201500605A1 (ru) | Новые производные замещенного 1,4-дитиина и их применение в качестве фунгицидов | |
EA201600323A1 (ru) | Производные пиперазина и их применение в качестве лекарственного средства | |
CO6700877A2 (es) | Derivado de difenil sulfuro y producto farmacéutico que contiene el mismo como ingrediente activo | |
MX2011010358A (es) | Derivados de 2-hidroxietil-1h-quinolin-2-ona y sus analogos azaisostericos con actividad antibacteriana. | |
MX336430B (es) | Derivados de dihidrofurano-azetadina como agentes antiparasitarios. | |
BR112013028368A2 (pt) | novos compostos de hexahidrociclopentapirrolona, hexahidropirrolopirrolona, octahidropirrolopiridinona e octahidropiridinona |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Application granted |